Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ASN-51 by Asceneuron for Alzheimer's Disease: Likelihood of Approval
ASN-51 is under clinical development by Asceneuron and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase I...
Data Insights
ASN-51 by Asceneuron for Parkinson's Disease: Likelihood of Approval
ASN-51 is under clinical development by Asceneuron and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase I...